SpineGuard SA announced sales results for the first quarter of 2022. For the quarter, the company reported global revenue of 1,131,000 against 1,049,000, 7.9% increase as reported in a context significantly impacted by the Omicron variant peaks of infection in January and February.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2385 EUR | -2.05% | -0.42% | +19.49% |
Apr. 17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+19.49% | 12.55M | |
+73.26% | 12.38B | |
-20.56% | 7.81B | |
+5.29% | 6.72B | |
+12.78% | 5.39B | |
+38.73% | 5.03B | |
-16.79% | 4.72B | |
-22.01% | 4.06B | |
-29.96% | 2.68B | |
+51.91% | 2.59B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard SA Announces Sales Results for the First Quarter of 2022